Small-Molecule Inhibitors of the SOX18 Transcription Factor.

[1]  P. Kolatkar,et al.  Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction , 2016, Nucleic acids research.

[2]  A. Mapp,et al.  Targeting transcription is no longer a quixotic quest. , 2015, Nature chemical biology.

[3]  J. Irwin,et al.  An Aggregation Advisor for Ligand Discovery. , 2015, Journal of medicinal chemistry.

[4]  S. Prabhakar,et al.  SOXE transcription factors form selective dimers on non-compact DNA motifs through multifaceted interactions between dimerization and high-mobility group domains , 2015, Scientific Reports.

[5]  M. Francois,et al.  Pharmacological manipulation of transcription factor protein-protein interactions: opportunities and obstacles , 2015, Cell Regeneration.

[6]  Kirill Alexandrov,et al.  Gateway-compatible vectors for high-throughput protein expression in pro- and eukaryotic cell-free systems. , 2015, Journal of biotechnology.

[7]  H. Dyson,et al.  Intrinsically disordered proteins in cellular signalling and regulation , 2014, Nature Reviews Molecular Cell Biology.

[8]  E. Cheung,et al.  Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factors , 2014, Cell Regeneration.

[9]  M. Smyth,et al.  Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor. , 2014, Cancer research.

[10]  D. Chan,et al.  Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening , 2014, Cell Death and Disease.

[11]  L. M. Stevers,et al.  Rapid Mapping of Interactions between Human SNX-BAR Proteins Measured In Vitro by AlphaScreen and Single-molecule Spectroscopy * , 2014, Molecular & Cellular Proteomics.

[12]  Wesley R. Legant,et al.  Single-Molecule Dynamics of Enhanceosome Assembly in Embryonic Stem Cells , 2014, Cell.

[13]  S. Stacker,et al.  VEGFD regulates blood vascular development by modulating SOX18 activity. , 2014, Blood.

[14]  Mark E. Polinkovsky,et al.  A cell-free approach to accelerate the study of protein–protein interactions in vitro , 2013, Interface Focus.

[15]  Dik-Lung Ma,et al.  DNA‐Binding Small Molecules as Inhibitors of Transcription Factors , 2013, Medicinal research reviews.

[16]  Ke Liu,et al.  Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development , 2013, Proceedings of the National Academy of Sciences.

[17]  L. Regan,et al.  Protein–protein interactions: General trends in the relationship between binding affinity and interfacial buried surface area , 2013, Protein science : a publication of the Protein Society.

[18]  K. Hochedlinger,et al.  The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. , 2013, Cell stem cell.

[19]  M. Vedadi,et al.  Thermal denaturation assays in chemical biology. , 2012, Assay and drug development technologies.

[20]  Zhong-Hui Duan,et al.  Amino acid function and docking site prediction through combining disease variants, structure alignments, sequence alignments, and molecular dynamics: a study of the HMG domain , 2012, BMC Bioinformatics.

[21]  Shyam Prabhakar,et al.  Deciphering the Sox-Oct partner code by quantitative cooperativity measurements , 2012, Nucleic acids research.

[22]  S. Blacklow,et al.  Conformational locking upon cooperative assembly of notch transcription complexes. , 2012, Structure.

[23]  K. Alexandrov,et al.  Leishmania cell-free protein expression system. , 2011, Methods.

[24]  E. Hazai,et al.  Identification of a polyoxometalate inhibitor of the DNA binding activity of Sox2. , 2011, ACS chemical biology.

[25]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[26]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[27]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[28]  Kirill Alexandrov,et al.  Species-independent translational leaders facilitate cell-free expression , 2009, Nature Biotechnology.

[29]  Hitoshi Niwa,et al.  A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells , 2009, Nature.

[30]  Juan M. Vaquerizas,et al.  A census of human transcription factors: function, expression and evolution , 2009, Nature Reviews Genetics.

[31]  G. Cohen,et al.  Bcl-2 inhibitors: small molecules with a big impact on cancer therapy , 2009, Cell Death and Differentiation.

[32]  G. Senisterra,et al.  High throughput methods of assessing protein stability and aggregation. , 2009, Molecular bioSystems.

[33]  F. Orsenigo,et al.  Sox18 induces development of the lymphatic vasculature in mice , 2008, Nature.

[34]  Olivier Sperandio,et al.  FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects , 2008, BMC Bioinformatics.

[35]  M. Vedadi,et al.  Application of High-Throughput Isothermal Denaturation to Assess Protein Stability and Screen for Ligands , 2008, Journal of biomolecular screening.

[36]  E. Dejana,et al.  Sox18 and Sox7 play redundant roles in vascular development. , 2008, Blood.

[37]  R. Roeder,et al.  Multivalent Binding of p53 to the STAGA Complex Mediates Coactivator Recruitment after UV Damage , 2008, Molecular and Cellular Biology.

[38]  Masoud Vedadi,et al.  Screening for Ligands Using a Generic and High-Throughput Light-Scattering-Based Assay , 2006, Journal of biomolecular screening.

[39]  Christos A. Ouzounis,et al.  Highly consistent patterns for inherited human diseases at the molecular level , 2006, Bioinform..

[40]  Michael G. Rosenfeld,et al.  Controlling nuclear receptors: the circular logic of cofactor cycles , 2005, Nature Reviews Molecular Cell Biology.

[41]  O. Dym,et al.  The modular architecture of protein-protein binding interfaces. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Muscat,et al.  The VCAM-1 Gene That Encodes the Vascular Cell Adhesion Molecule Is a Target of the Sry-related High Mobility Group Box Gene, Sox18* , 2004, Journal of Biological Chemistry.

[43]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[44]  Johannes Buchner,et al.  The N-terminal domain of p53 is natively unfolded. , 2003, Journal of molecular biology.

[45]  M. Bianchi,et al.  HMGB proteins and gene expression. , 2003, Current opinion in genetics & development.

[46]  J. Darnell.  Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.

[47]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[48]  Shen-Liang Chen,et al.  SOX18 directly interacts with MEF2C in endothelial cells. , 2001, Biochemical and biophysical research communications.

[49]  J. Bowles,et al.  Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. , 2000, Developmental biology.

[50]  E. Jabs,et al.  Online Mendelian Inheritance in Man (OMIM) as a knowledgebase for human developmental disorders , 2000, Clinical genetics.

[51]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[52]  G. Weissmann,et al.  Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Shrake,et al.  Origins and consequences of ligand‐induced multiphasic thermal protein denaturation , 1992, Biopolymers.

[54]  I. Mian,et al.  Structure, function and properties of antibody binding sites. , 1991, Journal of molecular biology.

[55]  J F Brandts,et al.  Study of strong to ultratight protein interactions using differential scanning calorimetry. , 1990, Biochemistry.

[56]  Peter Goodfellow,et al.  A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes , 1990, Nature.

[57]  A. Shrake,et al.  Ligand-induced biphasic protein denaturation. , 1990, The Journal of biological chemistry.

[58]  A. Ullrich,et al.  Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha , 1988, Molecular and cellular biology.

[59]  E. London,et al.  Fluorimetric determination of critical micelle concentration avoiding interference from detergent charge. , 1984, Analytical biochemistry.

[60]  J M Sturtevant,et al.  Thermodynamics of the binding of L-arabinose and of D-galactose to the L-arabinose-binding protein of Escherichia coli. , 1983, The Journal of biological chemistry.

[61]  Naoki Asao,et al.  Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. , 2011, The Journal of investigative dermatology.

[62]  W. J. Powers,et al.  An improved resazurin-based cytotoxicity assay for hepatic cells , 2004, Cell Biology and Toxicology.

[63]  Miklos Feher,et al.  Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..

[64]  C. Abbott,et al.  Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice , 2000, Nature Genetics.